We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEPI Announces Ninth COVID-19 Vaccine Development Partnership

Product News   May 05, 2020

 
CEPI Announces Ninth COVID-19 Vaccine Development Partnership
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Specialized MAT Reagents for Accurate and Reliable In Vitro Pyrogen Testing

Product News

Lonza and Sanquin have entered into a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test.

READ MORE

Autoscribe Release New and Improved Pharmaceutical-Specific LIMS Solution

Product News

Autoscribe Informatics has announced the release of a new and improved Matrix Gemini Pharmaceutical/Manufacturing LIMS to meet the changing needs of the pharmaceutical, manufacturing and regulated industries.

READ MORE

IRBM’s Advent Manufactures 13,000 Doses of COVID-19 Vaccine for Use in Phase 2/3 Clinical Trials

Product News

Advent has manufactured 13,000 doses of the novel COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (now known as AZD1222) for use in the Phase 2/3 clinical trial COV002 by the University of Oxford.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE